H.R. 9969, called Baby Brent's Bill, directs the Federal Trade Commission to investigate and regulate advertising and marketing practices for preterm infant formula. The bill requires the FTC to examine whether manufacturers are using unfair or deceptive advertising, particularly regarding health risks and differences between human milk-based fortifiers and bovine-based fortifiers, with the investigation to be completed within one year of enactment. The FTC must then issue regulations prohibiting deceptive advertising practices within eighteen months of submitting its report, with enforcement handled through existing FTC authority. The bill reflects congressional concern that one baby dies daily from necrotizing enterocolitis, a serious gastrointestinal condition affecting premature infants, and aims to ensure parents receive full information about infant feeding options and that families can pursue legal compensation if their preterm infants are harmed. The legislation affects manufacturers and importers of preterm infant formula, which includes any formula designed for infants born before 37 weeks of gestation or with low birth weight.